CytoSorbents Corporation (CTSO)

[orangecat]

It sounded to me more like CV19 treatement use in some EU countries was over estimated.

Dr. Chan: So, I think that what we found was that there were a lot of – some of the backlog that we had came from countries where COVID peaked actually very quickly and this happened in a number of European countries for example where either the outbreak was not as bad as predicted for example in Germany or where again COVID peaked quickly and then went away. And so in fact some of those, some of that backlog we never had a chance to fulfill, because those devices were not needed at the end of the day.